ArticleUrology case reports2025
Very rare synchronous malignant tumors of the Prostate: Leiomyosarcoma and adenocarcinoma - A case report and literature review.
Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Two faces of malignancy in one prostate: A rare coexistence of adenocarcinoma and leiomyosarcoma.Urology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostatic sarcoma accounts for 0.7 % of primary prostatic tumors, with leiomyosarcoma being the most common type (25 %). One-third of patients present with metastatic disease at diagnosis, and its expected behavior is that of an aggressive tumor. Additionally, the synchronous coexistence of two different primary tumors in the prostate is extremely rare in the literature. We present the case of a patient with two synchronous, distinct primary prostate malignancies: acinar adenocarcinoma and leiomyosarcoma. To our knowledge, this association has been reported in only two cases. Due to its rarity, there aren't standardized treatment guidelines, and its management requires a multidisciplinary approach.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.